Top Markets
Coin of the day
BCAL Diagnostics Limited BCAL Diagnostics Limited

BCAL Diagnostics Limited

BDX
株式のランク #31189
BCAL Diagnostics Limited is a biotechnology firm focused on creating an... BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
株価
$0.03808538
時価総額
$14.04M
変化(1日)
-3.57%
変化(1年)
6.63%
AU
取引 BCAL Diagnostics Limited (BDX)

カテゴリー

BCAL Diagnostics Limited(BDX)の配当利回りの履歴
BCAL Diagnostics Limited(銘柄コード: BDX)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
BCAL Diagnostics Limited(BDX)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)